Travoprost Ophthalmic Solution Solution/ Drops
Product Images NDC 46708-625

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic Solution (NDC 46708-625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travo-2-5-ml-bottle-ltd (Travo 2 5 mL Bottle Ltd)

This is a description of an ophthalmic solution with the active ingredient ravoprost USP at a concentration of 0.004%. The dosage information can be found in the insert. The solution is a buffered solution. It should be stored at 2-25 degrees Celsius. The text also mentions that it is for topical use. There is an area specified for coding information on the product packaging. Furthermore, there is an expiration date mentioned as 200XXXXX.*

FDA Label Image

Travo-2-5-ml-carton-ltd (Travo 2 5 mL Carton Ltd)

This is a description of Travoprost Ophthalmic Solution USP 0.004%. The solution is a sterile, ionic buffered solution intended for ophthalmic use. It contains active ingredient Travoprost USP 0.004% along with various inactive ingredients. The recommended storage temperature is between 2-25°C. The dosage instructions advise applying the solution on the eye(s) and avoiding contact with the surrounding areas. It is essential to keep this product out of the reach of children. Please consult with a healthcare professional for proper usage and any additional information.*

FDA Label Image

Travo-5-ml-bottle-ltd (Travo 5 mL Bottle Ltd)

FDA Label Image

Travo-5-ml-carton-ltd (Travo 5 mL Carton Ltd)

FDA Label Image

Travo-structure (Travo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.